Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | https://doi.org/10.9734/BJMMR/2016/23476 http://hdl.handle.net/1843/57529 |
Resumo: | Introduction: It is known that laboratorial tests (urinary albumin excretion and glomerular filtration rate), routinely used for nephropathy diagnosis in type 1 diabetes (T1DM), have limitations that justify the evaluation of new renal biomarkers. This study assessed the performance of cystatin C, alkaline phosphatase (AP) and gamma-glutamyl transferase (GGT) for nephropathy diagnosis in T1DM patients. The reduction of economic cost and increase in sensibility and specificity from correct biochemical diagnosis of diabetic nephropathy is an important objective of this work. Methods: Cystatin C, AP and GGT were determined in plasma and urine of healthy individuals (N=35) and T1DM patients with (N=45) and without nephropathy (N=80). Results: The plasma levels of cystatin C, AP and GGT, as well as urinary levels of cystatin C and AP were able to differentiate diabetic patients with and without nephropathy. Plasma cystatin C better followed the progression of albuminuria. Cystatin C and AP discriminated the onset of nephropathy in T1DM patients better than creatinine. AP plasma/urine ratio progressively increased from the controls to the diabetic patients without and with nephropathy. Conclusion: The plasma levels of cystatin C and AP may be useful, with the classical markers of renal function, for nephropathy diagnosis and monitoring in T1DM patients. |
id |
UFMG_34336ae984af4bd1e98dbe1cbe1c71d5 |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/57529 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
2023-08-07T15:26:55Z2023-08-07T15:26:55Z2016153114https://doi.org/10.9734/BJMMR/2016/234762231-0614http://hdl.handle.net/1843/57529Introduction: It is known that laboratorial tests (urinary albumin excretion and glomerular filtration rate), routinely used for nephropathy diagnosis in type 1 diabetes (T1DM), have limitations that justify the evaluation of new renal biomarkers. This study assessed the performance of cystatin C, alkaline phosphatase (AP) and gamma-glutamyl transferase (GGT) for nephropathy diagnosis in T1DM patients. The reduction of economic cost and increase in sensibility and specificity from correct biochemical diagnosis of diabetic nephropathy is an important objective of this work. Methods: Cystatin C, AP and GGT were determined in plasma and urine of healthy individuals (N=35) and T1DM patients with (N=45) and without nephropathy (N=80). Results: The plasma levels of cystatin C, AP and GGT, as well as urinary levels of cystatin C and AP were able to differentiate diabetic patients with and without nephropathy. Plasma cystatin C better followed the progression of albuminuria. Cystatin C and AP discriminated the onset of nephropathy in T1DM patients better than creatinine. AP plasma/urine ratio progressively increased from the controls to the diabetic patients without and with nephropathy. Conclusion: The plasma levels of cystatin C and AP may be useful, with the classical markers of renal function, for nephropathy diagnosis and monitoring in T1DM patients.Introdução: Sabe-se que os exames laboratoriais (excreção urinária de albumina e taxa de filtração glomerular), rotineiramente utilizados para o diagnóstico de nefropatia no diabetes tipo 1 (DM1), apresentam limitações que justificam a avaliação de novos biomarcadores renais. Este estudo avaliou o desempenho da cistatina C, fosfatase alcalina (FA) e gama-glutamil transferase (GGT) para o diagnóstico de nefropatia em pacientes com DM1. A redução do custo econômico e aumento da sensibilidade e especificidade do correto diagnóstico bioquímico da nefropatia diabética é um importante objetivo deste trabalho. Métodos: Cistatina C, AP e GGT foram determinados no plasma e na urina de indivíduos saudáveis (N=35) e pacientes com DM1 com (N=45) e sem nefropatia (N=80). Resultados: Os níveis plasmáticos de cistatina C, AP e GGT, assim como os níveis urinários de cistatina C e AP foram capazes de diferenciar pacientes diabéticos com e sem nefropatia. A cistatina C plasmática acompanhou melhor a progressão da albuminúria. A cistatina C e AP discriminaram melhor o aparecimento de nefropatia em pacientes com DM1 do que a creatinina. A razão AP plasma/urina aumentou progressivamente dos controles para os pacientes diabéticos sem e com nefropatia. Conclusão: Os níveis plasmáticos de cistatina C e AP podem ser úteis, juntamente com os marcadores clássicos da função renal, para diagnóstico e monitoramento de nefropatia em pacientes com DM1.CNPq - Conselho Nacional de Desenvolvimento Científico e TecnológicoCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorengUniversidade Federal de Minas GeraisUFMGBrasilFAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICASMED - DEPARTAMENTO DE CLÍNICA MÉDICAVET - DEPARTAMENTO DE MEDICINA VETERINÁRIA PREVENTIVAJournal of Advances in Medicine and Medical ResearchNefropatias diabéticasCistatina CFosfatase alcalinaGama-glutamilciclotransferaseDiabetic nephropathyCystatin CAlkaline phosphataseGamma-glutamyl transferasePerformance of new biomarkers of nephropathy in patients with type 1 diabetes mellitusinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://journaljammr.com/index.php/JAMMR/issue/view/68Manuelle Maria Pereira NatividadeCaroline Pereira DominguetiAna Paula Salles Moura FernandesRodrigo Bastos FóscoloJanice Sepúlveda ReisLuci Maria SantAna DusseCamila Stefanie Fonseca de OliveiraJoão Paulo Amaral HaddadLara Carvalho GodoiKarina Braga Gomes BorgesHenrique Pimenta Barroso Magalhãesapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/57529/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALPerformance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus.pdfPerformance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus.pdfapplication/pdf3216182https://repositorio.ufmg.br/bitstream/1843/57529/2/Performance%20of%20new%20biomarkers%20of%20nephropathy%20in%20patients%20with%20type%201%20diabetes%20mellitus.pdf6feedb36ab32d4f69c1c77b6dc51f8f3MD521843/575292023-08-07 14:05:59.065oai:repositorio.ufmg.br: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Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-08-07T17:05:59Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.pt_BR.fl_str_mv |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus |
title |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus |
spellingShingle |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus Manuelle Maria Pereira Natividade Diabetic nephropathy Cystatin C Alkaline phosphatase Gamma-glutamyl transferase Nefropatias diabéticas Cistatina C Fosfatase alcalina Gama-glutamilciclotransferase |
title_short |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus |
title_full |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus |
title_fullStr |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus |
title_full_unstemmed |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus |
title_sort |
Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus |
author |
Manuelle Maria Pereira Natividade |
author_facet |
Manuelle Maria Pereira Natividade Caroline Pereira Domingueti Ana Paula Salles Moura Fernandes Rodrigo Bastos Fóscolo Janice Sepúlveda Reis Luci Maria SantAna Dusse Camila Stefanie Fonseca de Oliveira João Paulo Amaral Haddad Lara Carvalho Godoi Karina Braga Gomes Borges Henrique Pimenta Barroso Magalhães |
author_role |
author |
author2 |
Caroline Pereira Domingueti Ana Paula Salles Moura Fernandes Rodrigo Bastos Fóscolo Janice Sepúlveda Reis Luci Maria SantAna Dusse Camila Stefanie Fonseca de Oliveira João Paulo Amaral Haddad Lara Carvalho Godoi Karina Braga Gomes Borges Henrique Pimenta Barroso Magalhães |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Manuelle Maria Pereira Natividade Caroline Pereira Domingueti Ana Paula Salles Moura Fernandes Rodrigo Bastos Fóscolo Janice Sepúlveda Reis Luci Maria SantAna Dusse Camila Stefanie Fonseca de Oliveira João Paulo Amaral Haddad Lara Carvalho Godoi Karina Braga Gomes Borges Henrique Pimenta Barroso Magalhães |
dc.subject.por.fl_str_mv |
Diabetic nephropathy Cystatin C Alkaline phosphatase Gamma-glutamyl transferase |
topic |
Diabetic nephropathy Cystatin C Alkaline phosphatase Gamma-glutamyl transferase Nefropatias diabéticas Cistatina C Fosfatase alcalina Gama-glutamilciclotransferase |
dc.subject.other.pt_BR.fl_str_mv |
Nefropatias diabéticas Cistatina C Fosfatase alcalina Gama-glutamilciclotransferase |
description |
Introduction: It is known that laboratorial tests (urinary albumin excretion and glomerular filtration rate), routinely used for nephropathy diagnosis in type 1 diabetes (T1DM), have limitations that justify the evaluation of new renal biomarkers. This study assessed the performance of cystatin C, alkaline phosphatase (AP) and gamma-glutamyl transferase (GGT) for nephropathy diagnosis in T1DM patients. The reduction of economic cost and increase in sensibility and specificity from correct biochemical diagnosis of diabetic nephropathy is an important objective of this work. Methods: Cystatin C, AP and GGT were determined in plasma and urine of healthy individuals (N=35) and T1DM patients with (N=45) and without nephropathy (N=80). Results: The plasma levels of cystatin C, AP and GGT, as well as urinary levels of cystatin C and AP were able to differentiate diabetic patients with and without nephropathy. Plasma cystatin C better followed the progression of albuminuria. Cystatin C and AP discriminated the onset of nephropathy in T1DM patients better than creatinine. AP plasma/urine ratio progressively increased from the controls to the diabetic patients without and with nephropathy. Conclusion: The plasma levels of cystatin C and AP may be useful, with the classical markers of renal function, for nephropathy diagnosis and monitoring in T1DM patients. |
publishDate |
2016 |
dc.date.issued.fl_str_mv |
2016 |
dc.date.accessioned.fl_str_mv |
2023-08-07T15:26:55Z |
dc.date.available.fl_str_mv |
2023-08-07T15:26:55Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1843/57529 |
dc.identifier.doi.pt_BR.fl_str_mv |
https://doi.org/10.9734/BJMMR/2016/23476 |
dc.identifier.issn.pt_BR.fl_str_mv |
2231-0614 |
url |
https://doi.org/10.9734/BJMMR/2016/23476 http://hdl.handle.net/1843/57529 |
identifier_str_mv |
2231-0614 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.none.fl_str_mv |
Journal of Advances in Medicine and Medical Research |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.publisher.initials.fl_str_mv |
UFMG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS MED - DEPARTAMENTO DE CLÍNICA MÉDICA VET - DEPARTAMENTO DE MEDICINA VETERINÁRIA PREVENTIVA |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
bitstream.url.fl_str_mv |
https://repositorio.ufmg.br/bitstream/1843/57529/1/License.txt https://repositorio.ufmg.br/bitstream/1843/57529/2/Performance%20of%20new%20biomarkers%20of%20nephropathy%20in%20patients%20with%20type%201%20diabetes%20mellitus.pdf |
bitstream.checksum.fl_str_mv |
fa505098d172de0bc8864fc1287ffe22 6feedb36ab32d4f69c1c77b6dc51f8f3 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
|
_version_ |
1803589553359945728 |